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Abstract
Background: Enhanced recovery after surgery (ERAS) protocols have been shown to reduce hospital
stay without compromising outcomes. Attempts to apply ERAS principles in the context of pancreatic
surgery have generated encouraging results. A systematic review of the current evidence for ERAS
following pancreatic surgery was conducted.
Methods: A literature search of MEDLINE, CINAHL, EMBASE and the Cochrane Library was performed
for articles describing postoperative clinical pathways in pancreatic surgery during the years 2000–2013.
The keywords ‘clinical pathway’, ‘critical pathway’, ‘fast-track’, ‘pancreas’ and ‘surgery’ and their syno-
nyms were used as search terms. Articles were selected for inclusion based on predefined criteria and
ranked for quality. Details of the ERAS protocols and relevant outcomes were extracted and analysed.
Results: Ten articles describing an ERAS protocol in pancreatic surgery were identified. The level of
evidence was graded as low to moderate. No articles reported an adverse effect of an ERAS protocol for
pancreatic surgery on perioperative morbidity or mortality. Length of stay (LoS) was decreased and
readmission rates were found to be unchanged in six of seven studies that compared these outcomes.
Conclusions: Evidence indicates that ERAS protocols may be implemented in pancreatic surgery
without compromising patient safety or increasing LoS. Enhanced recovery after surgery programmes in
the context of pancreatic surgery should be standardized based upon the best available evidence, and
trials of ERAS programmes involving multiple centres should be performed.
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Introduction
Pancreatic surgery has undergone immense transformations in
the century since it was first performed.1 The initial perioperative
mortality rate of 30% has decreased to 2% at high-volume centres,
and perioperative morbidity has decreased to 30%.2 Rates of read-
mission to hospital within 30 days of discharge range from 15% to
59%; one recent publication reported a 30-day readmission rate of
18%.3 Reasons for readmission include postoperative complica-
tions, failure to thrive and diagnostic evaluation; the median
length of stay (LoS) following readmission is 7 days. One of the
factors often credited with improving outcomes following pancre-
atic surgery has been the regionalization of pancreatectomy to
high-volume ‘centres of excellence’. Although the true impact of
such regionalization is controversial,4 a recent systematic review
by Torre et al. found improved 5-year survival and negative
margin status rates at high-volume centres compared with low-
volume centres.5 As pancreatic cancer remains the fourth leading
cause of cancer death in North America, advances in the field of
surgical oncology have generated interest in the management of
patients following oncologic resection of the pancreas.6 ‘Enhanced
recovery after surgery’ (ERAS) and related programmes, including
‘clinical pathway’, ‘fast track’ and ‘critical pathway’ protocols, are
multidisciplinary management plans for patients following
surgery. These protocols standardize a patient’s course in hospital
from surgery until discharge, and dictate when certain events (e.g.
catheter removal, dietary advancement) are to occur. By prescrib-
ing specific perioperative processes of care, these instruments have
the potential to improve quality of care by standardizing
perioperative care for patients and thereby decreasing variations
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in care. An ERAS protocol also facilitates the incorporation of
evidence-based practices into clinical care. Furthermore, these
tools can improve the efficiency of care delivery, which results in a
reduced hospital LoS. Encouraging results of the implementation
of ERAS programmes in other areas, particularly in colorectal
surgery, have prompted the application of ERAS protocols to
myriad operations ranging from cardiovascular to complex cancer
procedures such as pancreatectomy.7
Programmes based on ERAS protocols following pancreatic
surgery have existed for over a decade.8 Common elements of an
ERAS protocol in the context of pancreatic surgery include goal-
directed mobilization, early oral intake, and specific instructions
for the use and management of surgical drains and nasogastric
tubes. The objective of these protocols is to decrease LoS without
compromising patient safety and outcomes. Systematic reviews of
ERAS programmes in abdominal surgery have recommended
their widespread implementation, but uptake to date has been
limited.9 To determine the applicability of ERAS protocols in pan-
createctomy, a systematic review of the evidence was performed.
Materials and methods
Literature search
Several databases were consulted and search strategies specific to
the sources were designed in consultation with an information
specialist. The search was designed to identify material published
from 2000 to 2013 using the electronic sources MEDLINE,
CINAHL, the Cochrane Library (systematic reviews and trials)
and EMBASE. The key terms ‘clinical pathway’, ‘critical pathway’,
‘fast track’, ‘enhanced recovery’, ‘pancreas’, ‘surgery’ and their syno-
nyms were used in various combinations. Duplicates were deleted.
To ensure that all relevant literature was captured, manual
searches of the reference lists of eligible studies were performed.
Selection criteria
Abstracts of identified articles were screened for inclusion based
on predefined eligibility criteria. Abstracts were excluded if they:
(i) did not describe an ERAS protocol implemented by the
author(s); (ii) focused on a single intervention in postoperative
care; (iii) measured the impact of intraoperative factors on post-
operative outcomes; (iv) did not measure any clinically meaning-
ful outcomes such as LoS, morbidity, mortality, etc.; (v)
represented a case series with fewer than 10 patient participants,
or (vi) did not represent the most recent publication of a single
research project. Lastly, systematic reviews were also excluded
from analysis.
Data extraction
A data collection form was developed and pilot-tested. Two
reviewers (DJK and MA) independently extracted data from all
included articles. Disagreements were resolved through consen-
sus. If consensus could not be reached, an additional reviewer
(ACW) was sought to resolve the dispute. Extracted data were
tabulated and analysed.
Data analysis
Details regarding the total numbers of eligible and included
studies were recorded. These data and the reasons for exclusion
were tabulated in a spreadsheet. The methodologic quality of all
included studies was assessed using the GRADE guidelines pro-
posed by Balshem et al.10 Qualitative and quantitative information
on major outcomes of interest such as LoS, overall morbidity,
pancreatic fistulae, delayed gastric emptying, biliary leak, intra-
abdominal abscess, wound infections, 60-day mortality rates,
30-day readmission rates, and total hospital costs were recorded, if
available. In addition, data on overall findings such as quality of
life, patient satisfaction, staff satisfaction and implementation
strategies were noted, if reported.
Results
The results of the literature search are presented in Fig. 1. This
search strategy yielded a total of 3247 citations. The full-text ver-
sions of 59 articles were retrieved. Fourteen articles met the inclu-
sion criteria and underwent data extraction; 10 were primary
research studies11–20 and four were systematic reviews.21–24 No
additional articles were identified after hand-searching the
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Figure 1 Systematic review search results
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reference lists of the included articles. Thus, a total of 10 articles
met the criteria for analysis.
The quality of these studies was assessed using GRADE guide-
lines.10 No high-quality studies were identified. Cohort studies
comparing multiple groups were labelled as being of moderate
quality. Single-group prospective studies were graded as low
quality. Seven articles11–13,15,16,19,20 were deemed to be of moderate
quality and three were of low quality.14,17,18 No randomized con-
trolled trials or prospective studies comparing multiple groups
were identified.
The characteristics of included studies are presented in Table 1.
Of the 10 articles, three were prospective single-group cohort
studies14,17,18 and seven were retrospective studies11–13,15,16,19,20 com-
paring outcomes in patients who underwent surgery after the
implementation of an ERAS protocol with those in historical
control subjects. Five studies examined exclusively patients under-
going pancreaticoduodenectomy,12,15,18–20 and four studies
included patients undergoing other forms of oncologic pancreatic
resection.11,13,14,17 One study examined only patients undergoing
distal pancreatectomy.16 Notably, each primary research article
was restricted in scope to a single institution. No multicentre
studies were identified.
The components of each ERAS protocol described are pre-
sented in Table 2. Nine out of 10 studies described protocols con-
taining six or more distinct elements.9–17 One study presented a
protocol which specified only four elements, although the descrip-
tion is unclear and the actual protocol implemented may have
included more elements.11 The elements most frequently included
in the ERAS protocols were: early oral intake; nasogastric tube
management; goal-directedmobilization, and surgical drain man-
agement. Six of the articles explicitly described discharge planning
as a component of the ERAS protocol.13,16–20 Only two pro-
tocols included postoperative octreotide administration,14,17 and
four protocols included routine administration of prokinetic
agents.14,17,19,20 The number of elements in the protocols analysed
in these studies ranged from four to 13 and the average number of
elements was eight.
The outcomes of the analysed studies are displayed in Table 3.
Of the seven studies in which outcomes in a control group
were compared with those in an ERAS group, six studies
reported a significant decrease in postoperative LoS in ERAS
patients.11,13,15,16,19,20 The reported LoS ranged from 7 days to
13 days.
Rates of 30-day readmission did not differ significantly
between conventional and ERAS care in six of the seven
studies.11–15,17–20 Among ERAS patients, rates of readmission
ranged from 3.5% to 15%.
Balzano et al., whose study on post-pancreaticoduodenectomy
ERAS protocols included the largest number of patients, reported
a decrease in postoperative morbidity among patients treated
according to the protocol.15 The other five studies assessing post-
operative complications found no significant change in overall
morbidity among ERAS patients.11–13,16,20 No study found an
increased rate of complications after implementing an ERAS
protocol.
All studies assessing postoperative mortality found equivalent
rates across patients treated conventionally and those treated with
an ERAS protocol.11–18,20 Mortality rates ranged from 1% to 4%.
Table 1 Characteristics of included studies of outcomes of enhanced recovery after surgery (ERAS) protocols
Authors Year Journal Study design Type of resection Patients, n
CC ERAS
Porter et al.11 2000 Annals of Surgical Oncology Retrospective Whipple, total pancreatectomy 68 80
Vanounou et al.12 2007 Journal of the American
College of Surgeons
Retrospective Whipple 64 145
Kennedy et al.13 2007 Journal of the American
College of Surgeons
Retrospective Whipple, total pancreatectomy 44 91
Berberat et al.14 2007 Journal of Gastrointestinal
Surgery
Prospective Whipple, distal pancreatectomy, total
pancreatectomy, central
pancreatectomy, duodenum-preserving
pancreatic head resection, segmental
pancreatectomy
NA 255
Balzano et al.15 2008 British Journal of Surgery Retrospective Whipple 252 252
Kennedy et al.16 2009 Journal of Gastrointestinal
Surgery





2011 Langenbeck's Archives of
Surgery




Robertson et al.18 2012 HPB Prospective Whipple NA 50
Nikfarjam et al.19 2013 Journal of the Pancreas Retrospective Whipple 21 20
Abu Hilal et al.20 2013 Pancreatology Retrospective Whipple 24 20
CC, conventional care; NA, not applicable.
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Four studies examined costs associated with postoperative care
following pancreatic surgery.11–13,16 Two of these studies found a
decrease in cost following the implementation of an ERAS proto-
col11,12 and two studies found no significant change.13,16
Discussion
Since their introduction by Kehlet in the 1990s, postoperative
ERAS programmes have been extensively studied.25 Although
randomized trials and meta-analyses have consistently reported
an advantage to ERAS over conventional care, these studies have
been performed predominantly in colorectal surgery patients.26
The results of this systematic review reveal that only a handful of
studies have examined ERAS programmes in the context of pan-
creatic surgery. None of these studies reported primary data. At
present, recommendations are based on evidence of low andmod-
erate quality.
The results of 10 primary clinical studies demonstrate that
ERAS protocols in pancreatic surgery result in unchanged or
decreased LoS, overall morbidity, perioperative mortality, and
rates of readmission to hospital. Thus, based on the results of this
systematic review and reviews conducted by others, it appears
that ERAS programmes in pancreatic surgery are safe and effec-
tive, and do not compromise the aforementioned outcomes.8,22,24
Studies examining the impact of implementing an ERAS protocol
in the context of pancreatic surgery in terms of reductions in the
cost of care reported results in favour of ERAS; however, it is
worth noting the substantial disparity between studies in absolute
values of perioperative costs, which emphasizes the need to stand-
ardize cost reporting.11–13,16
This study also revealed substantial heterogeneity in the content
of ERAS protocols in pancreatic surgery. For example, whereas
most protocols included some form of early goal-directed
mobilization, what this entailed differed between protocols. Di






















Porter et al.11 + − − − + + − + − − − 4
Vanounou et al.12 + + − − + + + + − − + 9
Kennedy et al.13 + + − + + + + + − + + 13
Berberat et al.14 + − + + − − + − + − + 6
Balzano et al.15 + + − + + + − − − − + 6
Kennedy et al.16 + + − + + + + + − + + 12
di Sebastiano et al.17 + + + + − + + + + + − 9
Robertson et al.18 + + − + + + − + − + + 10
Nikfarjam et al.19 + + − − + + + + + + + 12
Abu Hilal et al.20 + + − + + + − − + + − 7
Total 10 8 2 7 8 9 6 7 4 6 7
+, element explicitly listed in the ERAS protocol; −, element not explicitly listed in the ERAS protocol.
PCA, patient-controlled analgesia; NG, nasogastric.
Table 3 Primary outcomes in studies of enhanced recovery after surgery (ERAS) protocols included in this review











CC ERAS CC ERAS CC ERAS CC ERAS CC ERAS CC ERAS
Porter et al.11 15 12a 10 (15%) 9 (11%) 20 (29%) 24 (30%) 1 (2%) 1 (1%) 2 (3%) 1 (1%) 47 515 36 627a
Vanounou et al.12 8 8 4 (6%) 13 (9%) 40 (62%) 77 (54%) 4 (6%) 7 (5%) 1 (2%) 2 (1%) 23 112 19 561
Kennedy et al.13 13 7a 3 (7%) 7 (8%) 19 (44%) 34 (37%) – – 1 (2%) 1 (1%) 240 242 126 566a
Berberat et al.14 – 10 (4–115) – 9 (4%) – 105 (41%) – 23 (9%) – 5 (2%) – –
Balzano et al.15 15 (7–102) 13 (7–110)a 16 (6%) 18 (7%) 148 (59%) 119 (47%)a 20 (8%) 17 (7%) 7 (3%) 9 (4%) – –
Kennedy et al.16 10 7a 10 (25%) 5 (7%)a 15 (38%) 11 (16%) – – 1 (2%) 1 (1%) 26 393 22 806
di Sebastiano et al.17 – 10 (6–69) – 9 (6%) – 56 (39%) – 11 (8%) – 4 (3%) – –
Robertson et al.18 – 10 (8–17) – 2 (4%) – 23 (46%) – 5 (10%) – 2 (4%) – –
Nikfarjam et al.19 14 (8–29) 8 (7–16)a 0 (0%) 3 (15%) – – – – – – – –
Abu Hilal et al.20 13 (11–20) 8 (7–13)a 2 (10%) 1 (4%) 16 (67%) 8 (40%) 3 (12%) 1 (5%) 0 (0%) 0 (0%) – –
aSignificant difference: P < 0.05.
CC, conventional care.
14 HPB
HPB 2015, 17, 11–16 © 2014 International Hepato-Pancreato-Biliary Association
Sebastiano et al. recommended mobilization for 4 h on the first
postoperative day,17 whereasAbuHilal et al. recommended that the
patient should sit out of bed for 2 h andundertake 30 s ofmarching
on the spot on postoperative day 1.20 Similar differences between
protocols exist in many other elements. Thus, it is difficult to
ascribe any beneficial outcome to a particular ERAS element and
impossible to recommend any one specific intervention as optimal.
Notably, in studies examining more than one type of pancreatec-
tomy, the ERAS protocols implemented were identical in different
operations,8,10,11,14 despite differences in resection and reconstruc-
tion. Kennedy et al. implemented extremely similar protocols in
patients undergoing Whipple and total pancreatectomy in one
study,13 and distal pancreatectomy in another,16 which suggests that
similar ERAS protocols can produce benefits when applied to
different operations. Moreover, the evidence for and rationale
underpinning each element are not reported inmost studies exam-
ining ERAS programmes in pancreatic surgery. The ERAS Society
recently published guidelines for perioperative care after
pancreaticoduodenectomy27 and made 27 evidence-based recom-
mendations. Future protocols should adhere to these guidelines.
The routine intraoperative placement of intraperitoneal drains
is controversial, with multiple publications suggesting that intra-
operative drain placement does not improve outcomes and may
actually worsen morbidity.28,29 Conversely, a recent randomized
prospective multicentre trial of pancreaticoduodenectomy with
and without routine drain placement was stopped early because
mortality increased from 3% to 12% in patients without intraperi-
toneal drainage.30 In the context of pancreatic surgery,ERASproto-
cols often include algorithms for drain management which may
indicate that drain amylase should be measured on a specific
postoperative day and the drain removed if the result is below a
specific threshold. Based on the evidence reviewed here, this strat-
egy is appropriate and is likely to evolve as future studies clarify the
role of intraoperative drain placement during pancreatectomy.
Emphasis on discharge planning varied substantially among
ERAS protocols. Some studies included explicit criteria to be met
prior to discharge, whereas others projected discharge on a spe-
cific postoperative day.What is not reported is the degree to which
patients and allied health care professionals (HCPs) were involved
in discharge planning. Future protocols might explicitly include
specific patient-centred discharge planning interventions.
Although ERAS protocols have the potential to improve out-
comes for patients undergoing pancreatic resection, their impact
is limited by variable implementation strategies. Simply develop-
ing evidence-based protocols is not sufficient to change practice.
Simultaneous strategies such as the initiation of patient educa-
tion, audit and feedback systems, and adherence to standards of
desired practice are required to ensure the effective implementa-
tion of ERAS protocols. In general, the reporting of implementa-
tion strategies was poor. Only three studies included standardized
sets of doctors’ orders as part of their implementation
process.11,13,16 Other implementation strategies reported include:
formal and informal education sessions for HCPs; patient educa-
tion sessions, and the use of pilot project results to inform the
future implementation of ERAS programmes. Although the ben-
eficial effects of audit and feedback on improving the practice of
HCPs and ameliorating patient outcomes have been demon-
strated,31 only one of the studies covered by this review included
audit and feedback as part of the ERAS implementation process.13
This shortcoming has been highlighted in other reviews on ERAS
programmes in hepatopancreatobiliary surgery.24
It must be noted that the introduction of ERAS programmes in
all of the studies included was limited to a single academic insti-
tution. This limits the external validity of these studies and their
applicability to other health care contexts. Interventions devel-
oped and tested in a single clinical environment are not neces-
sarily generalizable. This highlights the need for multicentre trials
of ERAS programmes in pancreatic surgery. Multicentre imple-
mentations of ERAS programmes have been reported in other
areas of general surgery; for example, the synchronous implemen-
tation of an ERAS programme for elective colonic surgery at 33
hospitals in the Netherlands resulted in a reduction in median
postoperative LoS from 9 days to 6 days.32 In addition to demon-
strating the feasibility of multicentre ERAS implementation,
this article provides strategies to encourage compliance with
multicentre ERAS programmes, which are highly applicable to
ERAS initiatives in the context of pancreatic surgery.
The present review is limited by its inability to pool the data
extracted using meta-analysis. Because of substantial clinical and
statistical heterogeneity, high-quality meta-analysis was not fea-
sible for any of the outcomes measured. Despite this limitation,
these findings remain meaningful for clinicians and eliminate
some of the contradiction among the findings of individual
studies. Most importantly, the preponderance of evidence favours
the standardization of postoperative care following pancreatic
surgery, in which severe complications are both frequent and vari-
able. Although postoperative complications necessitate deviation
from ERAS protocols, establishing a baseline pattern of care to be
followed in patients without complications is safe and effective,
and has the potential to shorten hospitalization and improve post-
operative outcomes. Future studies on ERAS protocols following
pancreatectomy should be randomized multicentre trials, and
should include data from both high- and low-volume centres in
their analysis.
Conclusions
This systematic review identified 10 primary studies of ERAS
programmes in elective pancreatic surgery. Although the quality
of evidence was low to moderate, ERAS protocols in pancreatic
surgery result in equivalent or better outcomes in terms of LoS,
morbidity, mortality and hospital readmission rates without evi-
dence of harm. Thus, ERAS programmes have the potential to
improve the quality and efficiency of perioperative care following
pancreatectomy. Future efforts should be directed towards devel-
oping ERAS protocols based on the best available evidence, incor-
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porating multifaceted implementation strategies, and evaluating
the impact of ERAS programmes in a multicentre framework at
both high- and low-volume centres.
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